Stay updated on Efficacy of EID Natalizumab in RRMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.

Latest updates to the Efficacy of EID Natalizumab in RRMS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe website revision tag was updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no other page content changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedIntroduced a 'Show glossary' option and updated page metadata to v3.4.0, including FEAR Act capitalization changes and the removal of the v3.3.4 entry in the deletions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe website changelog now includes Revision: v3.3.4 and removes Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated with numerous new site locations across the US, Canada, the UK, Spain, Australia, and other regions, and the previous location list was removed. The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check91 days agoChange DetectedThe page updates the note about publications to indicate they are automatically filled from PubMed and changes the revision to v3.3.2, replacing the previous wording that stated PubMed publications are automatically created and using revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efficacy of EID Natalizumab in RRMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.